The political dynamics of drug pricing are much different Monday (March 23) than they were before the weekend. Health care extenders are a part of the latest stimulus bills pushed by both parties, which removes a future vehicle for drug pricing legislation. A couple administrative drug pricing options remain, but some lobbyists and analysts believe the administration is less likely to move forward on its the International Pricing Index plan now that it needs the drug industry to develop COVID-19...